These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21986369)

  • 21. Membrane permeability of redox active metal chelators: an important element in reducing hydroxyl radical induced NAD+ depletion in neuronal cells.
    Jayasena T; Grant RS; Keerthisinghe N; Solaja I; Smythe GA
    Neurosci Res; 2007 Mar; 57(3):454-61. PubMed ID: 17210195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological properties of iron chelators based on a bis-2-(2-hydroxy-phenyl)-thiazole-4-carboxamide or -thiocarboxamide (BHPTC) scaffold.
    Rodriguez-Lucena D; Gaboriau F; Rivault F; Schalk IJ; Lescoat G; Mislin GL
    Bioorg Med Chem; 2010 Jan; 18(2):689-95. PubMed ID: 20036563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antiproliferating activity of iron chelators of hydroxyamino-1,3,5-triazine family.
    Sun D; Melman G; Letourneau NJ; Hays AM; Melman A
    Bioorg Med Chem Lett; 2010 Jan; 20(2):458-60. PubMed ID: 20005708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD; Evans RW; Evans PJ; Hider RC
    Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron chelators can protect against oxidative stress through ferryl heme reduction.
    Reeder BJ; Hider RC; Wilson MT
    Free Radic Biol Med; 2008 Feb; 44(3):264-73. PubMed ID: 18215735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron chelation properties of an extracellular siderophore exochelin MN.
    Dhungana S; Miller MJ; Dong L; Ratledge C; Crumbliss AL
    J Am Chem Soc; 2003 Jun; 125(25):7654-63. PubMed ID: 12812507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolution of iron chelators for the treatment of iron overload disease and cancer.
    Kalinowski DS; Richardson DR
    Pharmacol Rev; 2005 Dec; 57(4):547-83. PubMed ID: 16382108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential application of iron chelators for the treatment of neurodegenerative diseases.
    Hider RC; Roy S; Ma YM; Le Kong X; Preston J
    Metallomics; 2011 Mar; 3(3):239-49. PubMed ID: 21344071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activity.
    Mrkvicková Z; Kovaríková P; Klimes J; Kalinowski D; Richardson DR
    J Pharm Biomed Anal; 2007 Mar; 43(4):1343-51. PubMed ID: 17166684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
    Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV
    J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron chelation equilibria, redox, and siderophore activity of a saccharide platform ferrichrome analogue.
    Dhungana S; Harrington JM; Gebhardt P; Möllmann U; Crumbliss AL
    Inorg Chem; 2007 Oct; 46(20):8362-71. PubMed ID: 17824601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron chelation properties of an extracellular siderophore exochelin MS.
    Dhungana S; Ratledge C; Crumbliss AL
    Inorg Chem; 2004 Oct; 43(20):6274-83. PubMed ID: 15446873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake.
    Ma Y; Roy S; Kong X; Chen Y; Liu D; Hider RC
    J Med Chem; 2012 Mar; 55(5):2185-95. PubMed ID: 22339047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refinement of protein Fe(II) binding characteristics utilizing a competition assay exploiting small molecule ferrous chelators.
    Koebke KJ; Batelu S; Kandegedara A; Smith SR; Stemmler TL
    J Inorg Biochem; 2020 Feb; 203():110882. PubMed ID: 31683123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of orally active iron chelators.
    Hider RC; Choudhury R; Rai BL; Dehkordi LS; Singh S
    Acta Haematol; 1996; 95(1):6-12. PubMed ID: 8604587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-performance liquid chromatography method for ferric iron chelators using a post-column reaction with Calcein Blue.
    Ariga T; Ito K; Imura Y; Yoshimura E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():48-53. PubMed ID: 25658515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron mobilization from asbestos by chelators and ascorbic acid.
    Lund LG; Aust AE
    Arch Biochem Biophys; 1990 Apr; 278(1):61-4. PubMed ID: 2321970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of U937 cells against oxidative injury by a novel series of iron chelators.
    Galey JB; Destrée O; Dumats J; Pichaud P; Marché J; Génard S; Bracciolli G; Le Capitaine L; Plessix H; Brambilla L; Cantoni O
    Free Radic Biol Med; 1998 Nov; 25(8):881-90. PubMed ID: 9840732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of metal chelators on the oxidative stability of model wine.
    Kreitman GY; Cantu A; Waterhouse AL; Elias RJ
    J Agric Food Chem; 2013 Oct; 61(39):9480-7. PubMed ID: 24001152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovering Novel and Diverse Iron-Chelators in Silico.
    Basu A; Sohn YS; Alyan M; Nechushtai R; Domb AJ; Goldblum A
    J Chem Inf Model; 2016 Dec; 56(12):2476-2485. PubMed ID: 28024407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.